The host Julie Rovner KFF Health News @jrovner Julie Rovner is chief Washington correspondent and host of KFF Health News' weekly health policy news podcast, "What the Health?" A noted expert on health policy issues, Julie is the author of the critically praised reference book "Health Care Politics and Policy A to Z," now in its third edition. As Vice President Kamala Harris appears poised to become the Democratic Party’s presidential nominee, health policy in general and reproductive health issues in particular are likely to have a higher profile. Harris has long been the Biden administration's point person on abortion rights and reproductive health and was active on other health issues while serving as California's attorney general.
Meanwhile, Congress is back for a brief session between presidential conventions, but efforts in the GOP-led House to pass the annual spending bills, due by Oct. 1, have run into the usual roadblocks over abortion-related issues. This week's panelists are Julie Rovner of KFF Health News, Stephanie Armour of KFF Health News, Rachel Cohrs Zhang of Stat, and Alice Miranda Ollstein of Politico.
Panelists Stephanie Armour KFF Health News @StephArmour1 Rachel Cohrs Zhang Stat News @rachelcohrs Alice Miranda Ollstein Politico @AliceOllstein Among the takeaways from this week's episode: President Joe Biden's decision to drop out of the presidential race has turned attention to his likely successor on the Democratic ticket, Vice President Kamala Harris. At this late hour in the campaign, she is expected to adopt Biden's health policies, though many anticipate she'll take a firmer stance on restoring Roe v. Wade .
And while abortion rights supporters are enthusiastic about Harris' candidacy, opponents are eager to frame her views as extreme. As he transitions from incumbent candidate to outgoing president, Biden is working to frame his legacy, including on health policy. The president has expressed pride that his signature domestic achievement, the Inflation Reduction Act, took on the pharmaceutical industry, including by forcing the makers of the most expensive drugs into negotiations with Medicare.
Yet, as with the Affordable Care Act's delayed implementation and results, most Americans have yet to see the IRA's potential effect on drug prices. Lawmakers continue to be hung up on federal government spending, leaving appropriations work undone as they prepare to leave for summer recess. Fights over abortion are, once again, gumming up the works.
In abortion news, Iowa's six-week limit is scheduled to take effect next week, causing rippling problems of abortion access throughout the region. In Louisiana, which added the two drugs used in medication abortions to its list of controlled substances, doctors are having difficulty using the pills for other indications. And doctors who oppose abortion are pushing higher-risk procedures, like cesarean sections, in lieu of pregnancy termination when the mother's life is in danger — as states with strict bans, like Texas and Louisiana, are reporting a rise in the use of surgeries, including hysterectomies, to end pregnancies.
The Government Accountability Office reports that many states incorrectly removed hundreds of thousands of eligible people from the Medicaid rolls during the "unwinding" of the covid-19 public health emergency's coverage protections. The Biden administration has been reluctant to call out those states publicly in an attempt to keep the process as apolitical as possible. Also this week, Rovner interviews Anthony Wright, the new executive director of the consumer health advocacy group Families USA.
Wright spent the past two decades in California, working with, among others, now-Vice President Kamala Harris on various health issues. Plus, for "extra credit," the panelists suggest health policy stories they read this week that they think you should read, too: Related Stories Elite Controllers: Do their genomes hold the key to curing HIV? Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs PrEPVacc HIV vaccine trial shows no reduction in infections Julie Rovner: NPR's " A Study Finds That Dogs Can Smell Your Stress — And Make Decisions Accordingly ," by Rachel Treisman. Alice Miranda Ollstein: Stat's " A Pricey Gilead HIV Drug Could Be Made for Dramatically Less Than the Company Charges ," by Ed Silverman, and Politico's " Federal HIV Program Set To Wind Down ," by Alice Miranda Ollstein and David Lim.
Stephanie Armour: Vox's " Free Medical School Won't Solve the Doctor Shortage ," by Dylan Scott. Rachel Cohrs Zhang: Stat's " How UnitedHealth Harnesses Its Physician Empire To Squeeze Profits out of Patients ," by Bob Herman, Tara Bannow, Casey Ross, and Lizzy Lawrence. Also mentioned on this week's podcast: States Newsroom's " Anti-Abortion Researchers Back Riskier Procedures When Pregnancy Termination Is Needed, Experts Say ," by Sofia Resnick.
KFF Health News' " Louisiana Reclassifies Drugs Used in Abortions as Controlled Dangerous Substances ," by Rosemary Westwood, WWNO. The New York Times' " Biden and Georgia Are Waging a Fight Over Medicaid and the Future of Obamacare ," by Noah Weiland. Credits Francis Ying Audio producer Emmarie Huetteman Editor This article was reprinted from khn.
org , a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF - the independent source for health policy research, polling, and journalism. KFF Health News.
